AVITA Medical, Inc. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
AVITA Medical, Inc. (RCEL) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$16.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-02-13
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $1.00K.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-03-31 was -$6.00K.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2021-09-30 was -$55.00K, a 143.31% decline year-over-year.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2021-03-31 was -$11.00K.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$16.00K.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$26.00K.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was $133.00K, a 4333.33% increase from fiscal 2020.
- AVITA Medical, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2020 was $3.00K, a 98.08% decline from fiscal 2019.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$16.00K 10-K · filed 2025-02-13 | |||
| 2023-09-30 | -$15.00K 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$26.00K 10-K · filed 2024-02-22 | |||
| 2022-09-30 | -$70.00K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$52.00K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$6.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$59.00K 10-K · filed 2023-02-23 | |||
| 2021-09-30 | -$55.00K 10-Q · filed 2021-11-08 | -$31.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$15.00K 10-Q · filed 2022-08-11 | $133.00K 10-K · filed 2023-02-23 | ||
| 2021-03-31 | -$11.00K 10-Q · filed 2022-05-12 | $145.00K 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $158.00K 10-KT · filed 2022-02-28 | |||
| 2020-09-30 | $127.00K 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $3.00K 10-KT · filed 2022-02-28 | |||
| 2020-03-31 | -$42.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $26.00K 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | -$22.00K 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | $156.00K 10-K · filed 2021-08-26 | |||
| 2018-06-30 | $102.00K 10-K · filed 2020-08-27 |